PROCHLORPERAZINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Prochlorperazine Maleate, and when can generic versions of Prochlorperazine Maleate launch?
Prochlorperazine Maleate is a drug marketed by Amneal, Bionpharma, Chartwell Rx, Duramed Pharms Barr, Glenmark Pharms Ltd, Ivax Sub Teva Pharms, Mylan, Novitium Pharma, Teva Pharms, and Zydus. and is included in thirteen NDAs.
The generic ingredient in PROCHLORPERAZINE MALEATE is prochlorperazine maleate. There are twenty-one drug master file entries for this compound. Twenty-one suppliers are listed for this compound. Additional details are available on the prochlorperazine maleate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Prochlorperazine Maleate
A generic version of PROCHLORPERAZINE MALEATE was approved as prochlorperazine maleate by NOVITIUM PHARMA on June 13th, 2022.
Summary for PROCHLORPERAZINE MALEATE
Pharmacology for PROCHLORPERAZINE MALEATE
Drug Class | Phenothiazine |